Soleno Therapeutics (SLNO) Cash from Investing Activities Growth (3y) (2016 - 2025)
Soleno Therapeutics (SLNO) Cash from Investing Activities Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -29.84% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 38.24% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -22.09% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,654.25% |
| Dec 31, 2024 | 692.44% |
| Sep 30, 2024 | 832.17% |
| Mar 31, 2024 | -2,965.63% |
| Dec 31, 2022 | -27.20% |
| Dec 31, 2021 | 57.88% |
| Sep 30, 2021 | 0.00% |
| Dec 31, 2020 | -31.36% |
| Dec 31, 2019 | 101.45% |
| Sep 30, 2019 | 505.96% |
| Jun 30, 2019 | -81.71% |
| Mar 31, 2019 | 19.26% |
| Dec 31, 2018 | -76.26% |
| Sep 30, 2018 | 84.16% |
| Mar 31, 2017 | -44.22% |
| Dec 31, 2016 | -293.38% |